Parkinson’s in Perspective podcast

Emerging cell therapy DA01 with BlueRock Therapeutics

0:00
31:57
Retroceder 15 segundos
Avanzar 15 segundos

Join us as we discuss BlueRock Therapeutic's new cell therapy DA01 currently in phase I clinical trials. Dr. Fasano and Dr. Enayetallah break down how this therapy has the potential to revolutionize the Parkinson's treatment landscape by providing tonic dopamine release and addressing underlying neuron degeneration.

Learn more about the clinical trial here.

Access the transcript here.

Otros episodios de "Parkinson’s in Perspective"